Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Lawrence Memorial Hospital
mi
from
Lawrence, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Lawrence Memorial Hospital
mi
from
Lawrence, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - McPherson
mi
from
McPherson, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - McPherson
mi
from
McPherson, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Newton
mi
from
Newton, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Newton
mi
from
Newton, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Parsons
mi
from
Parsons, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Parsons
mi
from
Parsons, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Pratt
mi
from
Pratt, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Pratt
mi
from
Pratt, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas-Wichita Medical Arts Tower
mi
from
Wichita, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas-Wichita Medical Arts Tower
mi
from
Wichita, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Associates in Women's Health
mi
from
Wichita, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Associates in Women's Health
mi
from
Wichita, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Via Christi Regional Medical Center
mi
from
Wichita, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Via Christi Regional Medical Center
mi
from
Wichita, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Winfield
mi
from
Winfield, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Winfield
mi
from
Winfield, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Bronson Battle Creek
mi
from
Battle Creek, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Bronson Battle Creek
mi
from
Battle Creek, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Saint John Hospital and Medical Center
mi
from
Detroit, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Saint John Hospital and Medical Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Green Bay Oncology - Escanaba
mi
from
Escanaba, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Green Bay Oncology - Escanaba
mi
from
Escanaba, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Hurley Medical Center
mi
from
Flint, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Hurley Medical Center
mi
from
Flint, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Genesys Hurley Cancer Institute
mi
from
Flint, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Genesys Hurley Cancer Institute
mi
from
Flint, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Spectrum Health Butterworth Hospital
mi
from
Grand Rapids, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Spectrum Health Butterworth Hospital
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Green Bay Oncology - Iron Mountain
mi
from
Iron Mountain, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Green Bay Oncology - Iron Mountain
mi
from
Iron Mountain, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Allegiance Health
mi
from
Jackson, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Allegiance Health
mi
from
Jackson, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Sparrow Hospital
mi
from
Lansing, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Sparrow Hospital
mi
from
Lansing, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Saint Mary's of Michigan
mi
from
Saginaw, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Saint Mary's of Michigan
mi
from
Saginaw, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Munson Medical Center
mi
from
Traverse City, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Munson Medical Center
mi
from
Traverse City, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Saint John Macomb-Oakland Hospital
mi
from
Warren, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Saint John Macomb-Oakland Hospital
mi
from
Warren, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Metro Health Hospital
mi
from
Wyoming, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Metro Health Hospital
mi
from
Wyoming, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Medini, Eitan MD (UIA Investigator)
mi
from
Alexandria, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Medini, Eitan MD (UIA Investigator)
mi
from
Alexandria, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Fairview Ridges Hospital
mi
from
Burnsville, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Fairview Ridges Hospital
mi
from
Burnsville, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Mercy Hospital
mi
from
Coon Rapids, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Mercy Hospital
mi
from
Coon Rapids, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Miller-Dwan Hospital
mi
from
Duluth, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Miller-Dwan Hospital
mi
from
Duluth, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Fairview Southdale Hospital
mi
from
Edina, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Fairview Southdale Hospital
mi
from
Edina, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Lake Region Healthcare Corporation-Cancer Care
mi
from
Fergus Falls, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Lake Region Healthcare Corporation-Cancer Care
mi
from
Fergus Falls, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Unity Hospital
mi
from
Fridley, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Unity Hospital
mi
from
Fridley, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Hutchinson Area Health Care
mi
from
Hutchinson, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Hutchinson Area Health Care
mi
from
Hutchinson, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Saint John's Hospital - Healtheast
mi
from
Maplewood, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Saint John's Hospital - Healtheast
mi
from
Maplewood, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
New Ulm Medical Center
mi
from
New Ulm, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
New Ulm Medical Center
mi
from
New Ulm, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
North Memorial Medical Health Center
mi
from
Robbinsdale, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
North Memorial Medical Health Center
mi
from
Robbinsdale, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Saint Cloud Hospital
mi
from
Saint Cloud, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Saint Cloud Hospital
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Park Nicollet Clinic - Saint Louis Park
mi
from
Saint Louis Park, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Park Nicollet Clinic - Saint Louis Park
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
United Hospital
mi
from
Saint Paul, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
United Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Saint Francis Regional Medical Center
mi
from
Shakopee, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Saint Francis Regional Medical Center
mi
from
Shakopee, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Lakeview Hospital
mi
from
Stillwater, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Lakeview Hospital
mi
from
Stillwater, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Ridgeview Medical Center
mi
from
Waconia, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Ridgeview Medical Center
mi
from
Waconia, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Rice Memorial Hospital
mi
from
Willmar, MN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Rice Memorial Hospital
mi
from
Willmar, MN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Creighton University Medical Center
mi
from
Omaha, NE
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Creighton University Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Alegent Health Bergan Mercy Medical Center
mi
from
Omaha, NE
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Alegent Health Bergan Mercy Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Alegent Health Lakeside Hospital
mi
from
Omaha, NE
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Alegent Health Lakeside Hospital
mi
from
Omaha, NE
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Rutherford Hospital
mi
from
Rutherfordton, NC
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Rutherford Hospital
mi
from
Rutherfordton, NC
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Mid Dakota Clinic, PC
mi
from
Bismarck, ND
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Mid Dakota Clinic, PC
mi
from
Bismarck, ND
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Saint Alexius Medical Center
mi
from
Bismarck, ND
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Saint Alexius Medical Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Sanford Roger Maris Cancer Center
mi
from
Fargo, ND
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Sanford Roger Maris Cancer Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Altru Cancer Center
mi
from
Grand Forks, ND
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Altru Cancer Center
mi
from
Grand Forks, ND
Click here to add this to my saved trials